LAMA5 and cancer: Proteomic analysis, such as that of pancreatic EV samples, has identified that cancer EVs contain a distinctive protein profile, where tumor-promoting candidates such as LAMA5 (laminin subunit alpha 5), SDCBP (Syndecan Binding Protein) and TENA (Tenascin-A) were found to be overexpressed [25].